The World Health Organization has issued its first-ever guidelines covering the diagnosis and management of type 1 diabetes in adults. Released on World Diabetes Day 2026, these guidelines target improvements in insulin availability and quality care, especially in low-resource settings. The recommendations aim to ensure that by 2030, all people with type 1 diabetes can obtain affordable insulin treatment and self-monitor blood glucose levels. This move is expected to significantly improve the lives of millions of adults living with the condition.
According to WHO, more than a century after insulin's discovery, many patients still lack access to the medication and related care needed for survival. In 2025, an estimated 9.5 million people worldwide lived with type 1 diabetes, with an additional half-million new diagnoses that year. This underscores the growing adult burden of the disease. The new guidelines are designed to help countries deliver optimal care, even in areas where health services are disrupted.
WHO Director of Noncommunicable Diseases and Mental Health Dr Søren Brostrøm highlighted that the new evidence-based recommendations will help countries provide better care for adults with type 1 diabetes. The guidance reinforces WHO's broader target to achieve universal affordable insulin and self-monitoring access by 2030. The organization has pledged to provide practical tools to help nations implement and track progress toward this goal.
The guidelines emphasize the importance of involving people living with type 1 diabetes in designing, implementing, and evaluating programs. This approach aligns with this year's World Diabetes Day theme of early action and timely diagnosis. By working together, governments and communities can ensure that adults with type 1 diabetes receive the care they need to manage their condition effectively.
The release of these guidelines marks a significant step forward in addressing the challenges faced by adults with type 1 diabetes. WHO's efforts to improve insulin availability and quality care will be crucial in reducing the burden of this disease. The organization is committed to supporting countries in implementing these guidelines and achieving the goal of universal affordable insulin and self-monitoring access by 2030.
The new guidelines are expected to have a positive impact on the lives of millions of adults living with type 1 diabetes. By improving access to affordable insulin and essential diabetes services, WHO aims to reduce the risk of complications and improve health outcomes for those affected. This, in turn, will help to reduce the economic burden of the disease on individuals, families, and communities.
As WHO continues to work toward its goal of universal affordable insulin and self-monitoring access by 2030, the organization is urging governments to take action. By implementing these guidelines and working together with communities, countries can make a significant difference in the lives of adults living with type 1 diabetes. The guidelines provide a roadmap for countries to follow, and WHO is committed to supporting their implementation.
Key points
- WHO aims to ensure that by 2030, all people with type 1 diabetes can obtain affordable insulin treatment and self-monitor blood glucose levels.
Reporting sources
- WHO releases inaugural guidelines for adult type‑1 diabetes care · kenya-today.com